Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis

Arthritis and Rheumatism

Volumn 65, Issue 6, 2013, Pages 1477-1486

  Nozawa, Kazuhisa ^a   Fujishiro, Maki ^a   Kawasaki, Mikiko ^a   Yamaguchi, Ayako ^a   Ikeda, Keigo ^a   Morimoto, Shinji ^a   Iwabuchi, Kazuhisa ^a   Yanagida, Mitsuaki ^a   Ichinose, Shouzo ^a   Morioka, Megumi ^b   Ogawa, Hideoki ^a   Takamori, Kenji ^a   Takasaki, Yoshinari ^a   Sekigawa, Iwao ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Nosan Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; CONNECTIVE TISSUE GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY; I KAPPA B; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 17; STROMELYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DBA 1 MOUSE; DISEASE COURSE; FEMALE; GENE EXPRESSION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLASTOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TH17 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED DBA; MICROARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878534109     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37902     Document Type: Article

References (36)

1. Sekigawa I, Yanagida M, Iwabuchi K, Kaneda K, Kaneko H, Takasaki Y, et al. Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-α antibody therapy. Clin Exp Rheumatol 2008; 26: 261-7. (Pubitemid 351659132)
2. Bradham DM, Igarashi A, Potter RL, Grotendorst GR,. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285-94. (Pubitemid 21909886)
3. Grotendorst GR,. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171-9. (Pubitemid 28077925)
4. Perbal B,. CCN proteins: multifunctional signalling regulators. Lancet 2004; 363: 62-4. (Pubitemid 38076928)
5. Takigawa M, Nakanishi T, Kubota S, Nishida T,. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 2003; 194: 256-66. (Pubitemid 36176888)
6. Nozawa K, Fujishiro M, Kawasaki M, Kaneko H, Iwabuchi K, Yanagida M, et al. Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res Ther 2009; 11: R174.
7. Grotendorst GR, Duncan MR,. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 2005; 19: 729-38. (Pubitemid 40617377)
8. Chujo S, Shirasaki F, Kondo-Miyazaki M, Ikawa Y, Takehara K,. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J Cell Physiol 2009; 220: 189-95.
9. Ikawa Y, Ng PS, Endo K, Kondo M, Chujo S, Ishida W, et al. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-β-induced mouse fibrosis. J Cell Physiol 2008; 216: 680-7.
10. Nakasa T, Shibuya H, Nagata Y, Niimoto T, Ochi M,. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 2011; 63: 1582-90.
11. Dong W, Zhu P,. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics. Autoimmun Rev 2012; 11: 844-51.
12. H17 development by cooperating with ROR nuclear receptors. Nature 2010; 464: 1381-5.
13. Huber M, Brustle A, Reinhard K, Guralnik A, Walter G, Mahiny A, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A 2008; 105: 20846-51.
14. Biswas PS, Gupta S, Chang E, Song L, Stirzaker RA, Liao JK, et al. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest 2010; 120: 3280-95.
15. Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, Daniel WG, et al. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2005; 25: 1008-13. (Pubitemid 40627847)
16. Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, et al. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 2002; 277: 44187-94. (Pubitemid 36157849)
17. Wu SH, Wu XH, Lu C, Dong L, Zhou GP, Chen ZQ,. Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int 2006; 69: 248-56. (Pubitemid 43323074)
18. Blaney Davidson EN, Vitters EL, Mooren FM, Oliver N, van den Berg WB, van der Kraan PM,. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum 2006; 54: 1653-61.
19. Manns JM, Uknis AB, Rico MC, Agelan A, Castaneda J, Arango I, et al. A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor. Arthritis Rheum 2006; 54: 2415-22. (Pubitemid 44205001)
20. Schett G,. Rheumatoid arthritis: inflammation and bone loss. Wien Med Wochenschr 2006; 156: 34-41. (Pubitemid 43235478)
21. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43: 250-8. (Pubitemid 30395732)
22. Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S,. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 2000; 43: 2523-30.
23. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203: 2673-82. (Pubitemid 44833343)
24. Nakae S, Nambu A, Sudo K, Iwakura Y,. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173-7. (Pubitemid 37467240)
25. Pollinger B,. IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis. J Mol Med 2012; 90: 613-24.
26. Zizzo G, De Santis M, Bosello SL, Fedele AL, Peluso G, Gremese E, et al. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin Immunol 2011; 138: 107-16.
27. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL,. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: 1910-4. (Pubitemid 36801431)
28. + T helper cells. Cell 2006; 126: 1121-33. (Pubitemid 44380299)
29. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-74. (Pubitemid 47300011)
30. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448: 480-3. (Pubitemid 47123514)
31. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B,. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-89. (Pubitemid 43214587)
32. H17 and regulatory T cells. Nature 2006; 441: 235-8.
33. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011; 34: 566-78.
34. Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O'Shea JJ,. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 2010; 21: 425-34.
35. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, Kock S, et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A 2002; 99: 11808-12. (Pubitemid 34994480)
36. H-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007; 8: 958-66. (Pubitemid 47300010)